| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/15/2008 | US7399827 For diagnosis and for vaccine based therapy of neoplasms of prostate, testis and uterus; inhibiting the growth of malignant cells expressing PAGE-4, and methods of inducing an enhanced immune response to PAGE-4-expressing cancers |
| 07/15/2008 | US7399824 PRO19680 antibodies |
| 07/15/2008 | US7399823 Antimicrobial theta defensins and methods of using same |
| 07/15/2008 | US7399752 Detection, calibration binding of ligand to nucleic acids |
| 07/15/2008 | US7399745 polypeptides, fragments and/or variants, used for treatment of metabolic disorders, such as diabetes and obesity; hypoglycemic agents |
| 07/15/2008 | US7399743 Targeted thrombosis |
| 07/15/2008 | US7399741 Notch |
| 07/15/2008 | US7399645 Formed by fusing a pinanediol bound to a solid support with a boronic or boric acid bound to a biomolecule; an array may be constructed by preparing the conjugate at a plurality of spatially distinct reaction sites on the solid support |
| 07/15/2008 | US7399630 Cell culture vessel having a polymer surface, a cell adhesion resistant material (CAR) bonded to the polymer (e.g., hyaluronic acid), and one or more peptides covalently bound to the CAR material that promote adherence of cells that do not adhere to the CAR layer in the absence of the peptides |
| 07/15/2008 | US7399625 Codes for scytalone dehydratase from a rice blast fungus that exhibits scytalone dehydratase activity in the presence of a scytalone dehydratase inhibitor |
| 07/15/2008 | US7399617 Method for producing an L-amino acid in an Escherichia bacterium via altering expression levels of target proteins |
| 07/15/2008 | US7399613 Sialic acid nucleotide sugars |
| 07/15/2008 | US7399612 VEGF-binding fusion proteins and nucleic acids encoding the same |
| 07/15/2008 | US7399601 Nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners |
| 07/15/2008 | US7399597 Epitope identification and modification for reduced allergenic activity in proteins targeted for transgenic expression |
| 07/15/2008 | US7399595 Means for the diagnosis and therapy of CTCL |
| 07/15/2008 | US7399593 Member of the TNF ligand family |
| 07/15/2008 | US7399592 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
| 07/15/2008 | US7399583 Mixing the HuR protein and the ARE-containing mRNA in the presence of the candidate inhibitor and in the absence of the candidate inhibitor; detecting and comparing the amount of complexes with the non-complexed mRNA/protein species; identifying a candidate inhibitor |
| 07/15/2008 | US7399477 Genome segment, vaccine; temperature sensitivity, dominant interference, or attenuation; therapeutics, to protect animals from diseases caused by influenza A viruses, and in particular, to protect horses from disease caused by equine influenza virus |
| 07/15/2008 | US7399476 Nucleic acid free ghost preparations |
| 07/15/2008 | US7399474 Administering to a vertebrate an amount of a polynucleotide operatively encoding at least an immunogenic portion of the csa operon and having at least about 15 nucleotides; for prevention of enterotoxigenic e. coli colonization (diarrhea) |
| 07/15/2008 | US7399473 Virus coat protein/receptor chimeras and method of use |
| 07/15/2008 | US7399471 Diagnosis of RH factor; using polypeptides to form antibodies; purified polypeptide capable of forming antigen binding structures with specificity for Rhesus D antigens for treating idiopathic thrombocytopenic purpura (ITP) or mistransfusion of Rhesus incompatible blood |
| 07/15/2008 | US7399465 Pharmaceutical compositions for treating arthritis and inflammatory disease |
| 07/15/2008 | US7399464 Polypeptides of the IFNα-7 gene |
| 07/15/2008 | US7399461 Prostate-specific membrane antigen and uses thereof |
| 07/15/2008 | CA2299049C Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
| 07/15/2008 | CA2290720C Nucleic acid binding polypeptide library |
| 07/15/2008 | CA2274149C Peptides and compounds that bind to a receptor |
| 07/15/2008 | CA2271857C Method for treating symptoms of diabetes |
| 07/15/2008 | CA2250861C Cyclic adhesion inhibitors |
| 07/15/2008 | CA2250630C Novel lantibiotic related to actagardine, and processes for the preparation and use thereof |
| 07/15/2008 | CA2244176C Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells |
| 07/15/2008 | CA2207103C Methods to identify hemochromatosis |
| 07/15/2008 | CA2144473C Pna synthesis using a base-labile amino protecting group |
| 07/15/2008 | CA2142370C T cell epitopes of ryegrass pollen allergen |
| 07/11/2008 | CA2592533A1 Novel gene encoding myb transcription factor involved in proanthocyanidin synthesis |
| 07/10/2008 | WO2008083331A2 Diagnostic and therapeutic target for autoimmune diseases and uses thereof |
| 07/10/2008 | WO2008083203A1 Identification of multivalent viral envelope protein epitopes |
| 07/10/2008 | WO2008083169A2 Compositions and methods for the treatment of immunologic disorders |
| 07/10/2008 | WO2008082519A2 Screening for cd93 (c1qrp)-associated polymorphism(s) in the diagnosis, prevention and treatment of autoimmune diseases |
| 07/10/2008 | WO2008082211A1 A polypeptide being capable of increasing the production of l-methionine, a microorganism that overexpresses said polypeptide and a process of preparing l-methionine in high yield using same |
| 07/10/2008 | WO2008081938A1 Use of thermostable biotin-binding protein and solid support having the protein bound thereto |
| 07/10/2008 | WO2008081812A1 Anti-tumor peptide and use thereof |
| 07/10/2008 | WO2008081701A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 07/10/2008 | WO2008081466A1 Tumor suppressor activating polypeptides and uses thereof |
| 07/10/2008 | WO2008081418A1 Glucagon-like protein-1 receptor (glp-1r) agonist compounds |
| 07/10/2008 | WO2008081025A1 Purification of factor xi |
| 07/10/2008 | WO2008081015A1 Treatment of prdc in pigs |
| 07/10/2008 | WO2008080989A1 Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof |
| 07/10/2008 | WO2008080985A1 Polynucleotide sequence for the inhibition of phospholamban synthesis |
| 07/10/2008 | WO2008080983A1 Trpm4-deficient transgenic mammals and use thereof |
| 07/10/2008 | WO2008080900A2 Methionine synthases with reduced product inhibition |
| 07/10/2008 | WO2008080505A1 Novel specific arabinose transporter from the yeast pichia stipitis, and uses thereof |
| 07/10/2008 | WO2008080468A1 Detection of individual t-cell reaction patterns against tumor-associated antigens (taa) in tumor patients as a basis for the individual therapeutic vaccination of patients |
| 07/10/2008 | WO2008080218A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 07/10/2008 | WO2008080208A1 Plant derived antibiotic peptide rich in glycine |
| 07/10/2008 | WO2008062158A3 Polypeptide monomers and dimers containing mutated ilt |
| 07/10/2008 | WO2008058942A3 Method of cell culture and method of treatment comprising a vepo protein variant |
| 07/10/2008 | WO2008054514A3 Differential expression profiling analysis of cell culture phenotypes and the uses thereof |
| 07/10/2008 | WO2008052798A3 Fgfr4 promotes cancer cell resistance in response to chemotherapeutic drugs |
| 07/10/2008 | WO2008049070A9 Il-17c antagonists and methods of using the same |
| 07/10/2008 | WO2008046964A3 Novel useful inhibitors |
| 07/10/2008 | WO2008043000A3 Ehrlicia canis diva (differentiate infected from vaccinated animals) |
| 07/10/2008 | WO2008033887A3 Methods for treating cancer |
| 07/10/2008 | WO2008027394A3 Constructs for enhancing immune responses |
| 07/10/2008 | WO2008021560A3 Dpp-iv resistant gip hybrid polypeptides with selectable properties |
| 07/10/2008 | WO2008020308A3 Identification of genes implicated in the virulence of streptococcus agalactiae |
| 07/10/2008 | WO2008012505A3 Gpi-anchored cell surface glycoprotein |
| 07/10/2008 | WO2008010096A3 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases |
| 07/10/2008 | WO2008004902A3 Protein, their fragment and use thereof |
| 07/10/2008 | WO2008001224A3 Polypeptides from neisseria meningitidis |
| 07/10/2008 | WO2007121318A3 Formulations for delivering insulin |
| 07/10/2008 | WO2007070372A3 Compositions and methods for inhibiting cellular proliferation |
| 07/10/2008 | WO2002102229A9 Diagnosing tumorigenicity and determining resistance to anticancer therapy |
| 07/10/2008 | WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling |
| 07/10/2008 | WO2001018173A3 Dominant negative neuropilin-1 |
| 07/10/2008 | US20080168588 DNA sequences from tcd genomic region of photorhabdus luminescens |
| 07/10/2008 | US20080168586 Brassica Plant Comprising a Mutant Fatty Acid Desaturase |
| 07/10/2008 | US20080168585 Transgenic drought and freeze resistant plants; crops with enhanced resistance to enviromental stresses |
| 07/10/2008 | US20080168584 Using vector transformation to insert plasmid which express antisense sequences which reduce proanthocyanidin (PA) in plant seed coats; enhancing feed quality and digestibility |
| 07/10/2008 | US20080168582 Nucleic acid molecules and other molecules associated with plants |
| 07/10/2008 | US20080168580 Plastid Transit Peptides |
| 07/10/2008 | US20080168579 Expression vector comprising nucleotide sequences coding polypeptide fusion comprising organelle targeting sequences; tissue targeted therapy; directed protein evolution |
| 07/10/2008 | US20080168578 Protein kinase stress-related proteins and methods of use in plants |
| 07/10/2008 | US20080168577 Signal transduction stress-related proteins and methods of use in plants |
| 07/10/2008 | US20080168574 Nucleotide sequences coding tumor antigen for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/10/2008 | US20080168573 Transgenic worms for use as bioreactor for expression of carboxylesterase-1for use in treatment of alzheimer's disease |
| 07/10/2008 | US20080168572 Nanoarchaeum genome, Nanoarchaeum polypeptides and nucleic acids encoding them and methods for making and using them |
| 07/10/2008 | US20080168571 Transgenic animal |
| 07/10/2008 | US20080167457 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/10/2008 | US20080167451 Method for isolating an intestinal cholesterol binding protein |
| 07/10/2008 | US20080167448 Immunoglobulin specific to prostate tumor associated protein (24P4C12) for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/10/2008 | US20080167447 Isolating collagen from abalone snail shells via sodium hydroxide pe-treatment followed by acetic acid wash under heat conditions |
| 07/10/2008 | US20080167446 Rgd-enriched gelatine-like proteins with enhanced cell binding |
| 07/10/2008 | US20080167385 Crystal Structure of Human Proliferating Cell Nuclear Antigen (Pcna) and Uses Thereof |
| 07/10/2008 | US20080167378 For the 14273 peroxisome proliferator activated receptor; antidiabetic agents, hyperlipidemia, obesity or anorexia; receptor binding assay; drug screening kits |
| 07/10/2008 | US20080167260 Nucleic acid sequences encoding peptides with utrophin spectrin-like repeats |
| 07/10/2008 | US20080167259 Incorporating polynucleotides encoding fusion proteins comprising CFTR peptide and DNA binding domain of transcriptional activator that binds to site on detectable gene into host cell ; gene expressing; drug screening, high throughput assay; enhances dimerization of CFTR protein; cystic fibrosis |